Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mandelli

Showing results (271-280 of 573) with videos related to

Pageof 58
Sort By:
Cancer Research|October 1, 1981
Glucocorticoid receptor determinations in leukemia patients using cytosol and whole-cell assaysS Iacobelli, V Natoli, P Longo, et al.
Blood|June 1, 1983
Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemiaL P Ruco, A Procopio, V Maccallini, et al.
British Journal of Haematology|December 1, 1989
CD7 positive acute myeloid leukaemia: a subtype associated with cell immaturityF Lo Coco, G De Rossi, D Pasqualetti, et al.
European Journal of Epidemiology|September 1, 1988
Emergence of penicillin-resistant viridans streptococci causing septicemia in granulocytopenic patientsC Santini, M Venditti, P Baiocchi, et al.
Seminars in Oncology|June 1, 1985
Treatment of diffuse aggressive non-Hodgkin's lymphomas with an intensive multi-drug regimen including high-dose cytosine arabinoside (F-MACHOP)S Amadori, C Guglielmi, A P Anselmo, et al.
Leukemia|October 3, 2002
How long can we give interleukin-2? Clinical and immunological evaluation of AML patients after 10 or more years of IL2 administrationG Meloni, S M Trisolini, S Capria, et al.
Cancer Investigation|January 1, 1987
Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP)C Guglielmi, S Amadori, A P Anselmo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma with or without antiretroviral therapy during antineoplastic agentsR Gastaldi, P Martino, G Gentile, et al.
Leukemia & Lymphoma|November 1, 1992
Prognostic value of the histologic classification of peripheral T-cell lymphoma: a clinico-pathologic study of 71 HTLV-1 negative casesD Remotti, E Pescarmona, V L Burgio, et al.
American Journal of Hematology|December 1, 1987
Evaluation of factor VII antigen in factor VII congenital deficiencies with a new ELISA assayM C Tirindelli, G Mariani, M G Mazzucconi, et al.
Pageof 58

Showing results (271-280 of 573) with videos related to

Sort By:
Pageof 58
Cancer Research|October 1, 1981
Glucocorticoid receptor determinations in leukemia patients using cytosol and whole-cell assaysS Iacobelli, V Natoli, P Longo, et al.
Blood|June 1, 1983
Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemiaL P Ruco, A Procopio, V Maccallini, et al.
British Journal of Haematology|December 1, 1989
CD7 positive acute myeloid leukaemia: a subtype associated with cell immaturityF Lo Coco, G De Rossi, D Pasqualetti, et al.
European Journal of Epidemiology|September 1, 1988
Emergence of penicillin-resistant viridans streptococci causing septicemia in granulocytopenic patientsC Santini, M Venditti, P Baiocchi, et al.
Seminars in Oncology|June 1, 1985
Treatment of diffuse aggressive non-Hodgkin's lymphomas with an intensive multi-drug regimen including high-dose cytosine arabinoside (F-MACHOP)S Amadori, C Guglielmi, A P Anselmo, et al.
Leukemia|October 3, 2002
How long can we give interleukin-2? Clinical and immunological evaluation of AML patients after 10 or more years of IL2 administrationG Meloni, S M Trisolini, S Capria, et al.
Cancer Investigation|January 1, 1987
Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP)C Guglielmi, S Amadori, A P Anselmo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma with or without antiretroviral therapy during antineoplastic agentsR Gastaldi, P Martino, G Gentile, et al.
Leukemia & Lymphoma|November 1, 1992
Prognostic value of the histologic classification of peripheral T-cell lymphoma: a clinico-pathologic study of 71 HTLV-1 negative casesD Remotti, E Pescarmona, V L Burgio, et al.
American Journal of Hematology|December 1, 1987
Evaluation of factor VII antigen in factor VII congenital deficiencies with a new ELISA assayM C Tirindelli, G Mariani, M G Mazzucconi, et al.
Pageof 58